Back to stock search

Regeneron Pharmaceuticals Inc

REGN•NASDAQ•HEALTHCARE
$676.23+26.42 (+4.07%)
Market closed•Prev close $649.81
Save to watchlist

Research read

Active interest

Evidence read

Smart-money activity on REGN this 14d.

Saved Jul 3, 2026· tracking vs the S&P 500

1 sourceLatest

Analyst estimate

+21.6% ($822.5)

12-month analyst consensus · Source: Alpha Vantage

Support

Industrial Production 102.6 (mild expansion) as of 2026-05-01

Risk

Review the sections below before acting.

Tracking

Day 5 of 30D, +0.0% vs the S&P so far.

What's driving it

  • Smart money
  • Fundamentals
  • Technicals
  • Macro
Set alertReview evidenceFundamentalsTechnicals

vs S&P 500. Past performance does not predict future results. Market research, not investment advice.

Section

Smart Money

Funds, insiders, influencers, and government demand tied to this stock — pulled straight from SEC filings, Form 4s, X posts, and federal award data.

Institutional

Who owns this in size

Live8 holders
  • B

    Q1 2026 13F

    BlackRock holds $6.9B

  • SS

    Q1 2026 13F

    State Street holds $3.6B

  • JC

    Q4 2025 13F

    JPMorgan Chase holds $3.0B

  • FL

    Q1 2026 13F

    FMR LLC holds $1.2B

  • A

    Q1 2026 13F

    AQR holds $946.0M

  • Two Sigma

    Q1 2026 13F

    Two Sigma holds $627.6M

  • Millennium

    Q4 2025 13F

    Millennium holds $293.1M

  • D.E. Shaw

    Q4 2025 13F

    D.E. Shaw holds $120.0M

    • Insiders

    What insiders are doing

    Live2 trades

    • Sell· Dir

      RYAN ARTHUR F sold $130K of REGENERON PHARMACEUTICALS, INC. · Jul 7

    • Sell· Dir

      RYAN ARTHUR F sold $71K of REGENERON PHARMACEUTICALS, INC. · May 4

    Influencers

    What traders are saying

    No data yet

    No influencer mentions in the last 30 days.

    X/Twitter finance posts tracked by AlphaYou

    Govt contracts

    Federal awards tied to this company

    Checking USAspending awards...

    Other smart money signals

    Congress trades, activist stakes, short interest & more

    Live2 items

    • short interest change

      short-volume tape softening: latest 43.0% fell 6.9pp vs 20d avg 49.9%

      Light

    • short interest change

      short-volume tape softening: latest 22.6% fell 19.5pp vs 20d avg 42.1%

      Moderate

    Section

    Fundamentals

    Business quality, valuation, analyst expectations, and the EPS quarter-over-quarter chart.

    Fundamentals

    Is the business strong?

    Live

    Valuation

    • P/E15.87
    • Forward P/E14.47
    • P/S4.75
    • P/B2.17

    Quality

    • Profit margin29.6%
    • Operating margin20.7%
    • ROE14.5%
    • ROA6.1%

    Growth

    • Revenue YoY--
    • Earnings YoY--
    • Beta0.24
    • Dividend yield0.5%

    Snapshot

    Quick facts

    Updated Jul 8
    Market cap
    $70.90B
    52-week range
    $538.55 - $818.90
    Volume
    918.9K
    Sector
    HEALTHCARE

    Analysts

    What do analysts expect?

    Live

    Current

    $676.23

    Target

    $822.48

    Earnings

    Did earnings help or hurt?

    Live
    $13.59$12.07$10.55$9.04$7.52Q2 '24Q4 '24Q2 '25Q4 '25Q1 '26
    BeatMissMatchEstimate

    Section

    Technicals

    Price trend, moving averages, 52-week range, and chart behavior.

    Price

    Stock chart

    2reads marked
    Prior read2

    Technicals

    Chart health

    Live

    Trailing returns

    • 5d+7.03%
    • 20d+6.42%
    • 60d-11.80%

    Trend vs moving averages

    • vs SMA50+3.49%
    • vs SMA200-3.29%

    52w range position

    $538.5549%$818.90

    Based on daily price data. Options flow and order-book data are not in this chart panel yet.

    Section

    Macro

    Sector rotation, market regime, policy, and event-window context.

    Macro

    Market backdrop

    Live

    • macro regime shift

      VIX 16.6 (mild) as of 2026-07-01

    • macro regime shift

      10y-2y spread 35bps (flattish) as of 2026-07-02

    • macro regime shift

      Industrial Production 102.6 (mild expansion) as of 2026-05-01

    • macro regime shift

      Initial claims 215,000 vs 26w mean (ratio 1.01, neutral)

    • macro regime shift

      CPI YoY 4.27% (hot vs Fed target)

    Section

    News

    Catalysts, filings, and market-moving events when they matter.

    News

    Catalysts and headlines

    No data yet

    No major news catalyst found yet.

    Catalysts, filings, and event windows show here when they matter.

    Section

    Derivatives

    Options flow, volatility regime, gamma pressure, and positioning when available.

    Derivatives

    Options and positioning

    No data yet

    No derivative pressure found yet.

    Options flow, gamma, and volatility signals show here when available.

    +146.25 (+21.6%) possible upside12 months

    12-month analyst consensus · Source: Alpha Vantage